✦ LIBER ✦

Treatment Decisions for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Chemotherapy: The Role of Cabazitaxel in the Continuum of Care

✍ Scribed by Axel Heidenreich; David Pfister

Book ID: 118440955
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 232 KB
Volume: 62
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2012.08.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prednisone plus cabazitaxel or mitoxantr

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

✍ Johann Sebastian de Bono; Stephane Oudard; Mustafa Ozguroglu; Steinbjørn Hansen; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 293 KB

Significance of docetaxel-based chemothe

Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75

✍ Hideaki Miyake, Iori Sakai, Ken-ichi Harada, Mototsugu Muramaki, Masato Fujisawa 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 322 KB

Phase II Trial of Sunitinib for the Ther

Phase II Trial of Sunitinib for the Therapy of Progressive Metastatic Castration-Refractory Prostate Cancer After Previous Docetaxel Chemotherapy

✍ Guru Sonpavde; Thomas E. Hutson; William R. Berry; Kristi A. Boehm; Lina Asmar 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 93 KB

PCN5 Cabazitaxel Plus Corticosteroids in

PCN5 Cabazitaxel Plus Corticosteroids in Comparison to Corticosteroids Alone for the Treatment of Metastatic Hormone Refractory / Castration-Resistant Prostate Cancer (mHRPC)

✍ S. Schinzel; M. Herbold; P. Bramlage 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

223 VERSICAN IS A PROMISING CANDIDATE BI

223 VERSICAN IS A PROMISING CANDIDATE BIOMARKER IN THE COMBINATION OF DOCETAXEL WITH THALIDOMIDE AS SECOND LINE CHEMOTHERAPY IN CASTRATION-RESISTANT PROSTATE CANCER AFTER DOCETAXEL RESISTANCE

✍ Shiina, Hiroaki; Yasumoto, Hiroaki; Hiraki, Miho; Arichi, Naoko; Mitsui, Yozo; H 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 62 KB

UP-02.062 Clinical, Biochemical and Radi

UP-02.062 Clinical, Biochemical and Radiologic Benefit of the Treatment with Sunitinib in Monotherapy for Patients with Metastatic Castration-Resistant Prostate Cancer After Failure of Docetaxel

✍ C. Casu; A. Rodriguez Antolin; D. Castellano; L. Anton Aparicio; J. Romero Otero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB